Report Detail
Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025
- RnM3889167 |
- 19 February, 2020 |
- Global |
- 109 Pages |
- GIR (Global Info Research) |
- Other
Market Overview
The global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.9% in the forecast period of 2020 to 2025 and will expected to reach USD 9300.5 million by 2025, from USD 7669.7 million in 2019.
The Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics market has been segmented into:
Oral Therapy
Injectable Therapy
By Application, Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics has been segmented into:
Hospitals & Clinics
Home Settings
Ambulatory Surgical Centers (ASCs)
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics market.
The report offers in-depth assessment of the growth and other aspects of the Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share Analysis
Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics sales, revenue and market share for each player covered in this report.
The major players covered in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics are:
Astellas Inc.
Dendreon Corporation
Johnson & Johnson
Sanofi S.A
Bayer AG
Table of Contents
1 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Overview
- 1.1 Product Overview and Scope of Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics
- 1.2 Classification of Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics by Type
- 1.2.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
- 1.2.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue Market Share by Type in 2019
- 1.2.3 Oral Therapy
- 1.2.4 Injectable Therapy
- 1.3 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market by Application
- 1.3.1 Overview: Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
- 1.3.2 Hospitals & Clinics
- 1.3.3 Home Settings
- 1.3.4 Ambulatory Surgical Centers (ASCs)
- 1.4 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market by Regions
- 1.4.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
- 1.4.2 Global Market Size of Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics (2015-2025)
- 1.4.3 North America (USA, Canada and Mexico) Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Status and Prospect (2015-2025)
- 1.4.4 Europe (Germany, France, UK, Russia and Italy) Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Status and Prospect (2015-2025)
- 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Status and Prospect (2015-2025)
- 1.4.6 South America (Brazil, Argentina, Colombia) Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Status and Prospect (2015-2025)
- 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
- 2.1 Astellas Inc.
- 2.1.1 Astellas Inc. Details
- 2.1.2 Astellas Inc. Major Business and Total Revenue (Financial Highlights) Analysis
- 2.1.3 Astellas Inc. SWOT Analysis
- 2.1.4 Astellas Inc. Product and Services
- 2.1.5 Astellas Inc. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
- 2.2 Dendreon Corporation
- 2.2.1 Dendreon Corporation Details
- 2.2.2 Dendreon Corporation Major Business and Total Revenue (Financial Highlights) Analysis
- 2.2.3 Dendreon Corporation SWOT Analysis
- 2.2.4 Dendreon Corporation Product and Services
- 2.2.5 Dendreon Corporation Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
- 2.3 Johnson & Johnson
- 2.3.1 Johnson & Johnson Details
- 2.3.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
- 2.3.3 Johnson & Johnson SWOT Analysis
- 2.3.4 Johnson & Johnson Product and Services
- 2.3.5 Johnson & Johnson Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
- 2.4 Sanofi S.A
- 2.4.1 Sanofi S.A Details
- 2.4.2 Sanofi S.A Major Business and Total Revenue (Financial Highlights) Analysis
- 2.4.3 Sanofi S.A SWOT Analysis
- 2.4.4 Sanofi S.A Product and Services
- 2.4.5 Sanofi S.A Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
- 2.5 Bayer AG
- 2.5.1 Bayer AG Details
- 2.5.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis
- 2.5.3 Bayer AG SWOT Analysis
- 2.5.4 Bayer AG Product and Services
- 2.5.5 Bayer AG Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
- 3.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Share by Players (2015-2020)
- 3.2 Market Concentration Rate
- 3.2.1 Top 5 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Players Market Share
- 3.2.2 Top 10 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Players Market Share
- 3.3 Market Competition Trend
4 Market Size by Regions
- 4.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Market Share by Regions
- 4.2 North America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Growth Rate (2015-2020)
- 4.3 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Growth Rate (2015-2020)
- 4.4 Asia-Pacific Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Growth Rate (2015-2020)
- 4.5 South America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Growth Rate (2015-2020)
- 4.6 Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Countries
- 5.1 North America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Countries (2015-2020)
- 5.2 USA Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Growth Rate (2015-2020)
- 5.3 Canada Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Growth Rate (2015-2020)
- 5.4 Mexico Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Countries
- 6.1 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Countries (2015-2020)
- 6.2 Germany Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Growth Rate (2015-2020)
- 6.3 UK Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Growth Rate (2015-2020)
- 6.4 France Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Growth Rate (2015-2020)
- 6.5 Russia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Growth Rate (2015-2020)
- 6.6 Italy Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Countries
- 7.1 Asia-Pacific Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Countries (2015-2020)
- 7.2 China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Growth Rate (2015-2020)
- 7.3 Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Growth Rate (2015-2020)
- 7.4 Korea Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Growth Rate (2015-2020)
- 7.5 India Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Growth Rate (2015-2020)
- 7.6 Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Countries
- 8.1 South America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Countries (2015-2020)
- 8.2 Brazil Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Growth Rate (2015-2020)
- 8.3 Argentina Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics by Countries
- 9.1 Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Countries (2015-2020)
- 9.2 Saudi Arabia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Growth Rate (2015-2020)
- 9.3 UAE Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Growth Rate (2015-2020)
- 9.4 Egypt Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Growth Rate (2015-2020)
- 9.5 South Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
- 10.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Market Share by Type (2015-2020)
- 10.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Forecast by Type (2019-2024)
- 10.3 Oral Therapy Revenue Growth Rate (2015-2025)
- 10.4 Injectable Therapy Revenue Growth Rate (2015-2025)
11 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Segment by Application
- 11.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue Market Share by Application (2015-2020)
- 11.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Forecast by Application (2019-2024)
- 11.3 Hospitals & Clinics Revenue Growth (2015-2020)
- 11.4 Home Settings Revenue Growth (2015-2020)
- 11.5 Ambulatory Surgical Centers (ASCs) Revenue Growth (2015-2020)
12 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Forecast (2021-2025)
- 12.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Forecast (2021-2025)
- 12.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Forecast by Regions (2021-2025)
- 12.3 North America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue Market Forecast (2021-2025)
- 12.4 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue Market Forecast (2021-2025)
- 12.5 Asia-Pacific Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue Market Forecast (2021-2025)
- 12.6 South America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue Market Forecast (2021-2025)
- 12.7 Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Data Source
- 14.3 Disclaimer
Summary:
Get latest Market Research Reports on Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics. Industry analysis & Market Report on Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics is a syndicated market report, published as Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025. It is complete Research Study and Industry Analysis of Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
